You can buy or sell MeiraGTx and other stocks, options, ETFs, and crypto commission-free!
MeiraGTx Holdings plc Ordinary Shares, also called MeiraGTx, is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Read More Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1, and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Yahoo FinanceMay 6
MeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference
LONDON and NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., president and chief executive officer, will present at the BAML Healthcare Conference on Wednesday, May 15, 2019, at 3:55 p.m. PST. Dr. Forbes will also be participating on the “Gene Therapy” panel at the BAML Healthcare Conference on Wednesday May 15, 2019 at 4:20 p.m. PST. A live webcast of MeiraGTx’s May 15th p...
-$0.64 per share
-$0.62 per share